Spanish payer Jaime Espín joins Omar Ali to discuss regulatory reform, transparency in pricing, and the evolving use of outcome-based payment models in Spain’s healthcare system.

Spain's plans to consolidate its IPT assessment arrangements faced delays due to legal challenges, reflecting difficulties in changing infrastructure. The intention was to introduce a formal economic analysis combined with clinical appraisals, similar to other established models. However, despite setbacks, there remains a shift towards emphasizing cost-effectiveness data and exploring innovative contracting, like risk-sharing outcome-based agreements, for medicines in Spain.